<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04581005</url>
  </required_header>
  <id_info>
    <org_study_id>MUHC 2019-5387</org_study_id>
    <nct_id>NCT04581005</nct_id>
  </id_info>
  <brief_title>Prehabilitation in Esophageal Cancer Care</brief_title>
  <official_title>Prehabilitation to Enhance Functional Capacity in Esophageal Cancer Care</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Centre/Research Institute of the McGill University Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McGill University Health Centre/Research Institute of the McGill University Health Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prehabilitation utilizes the preoperative period to prevent or attenuate the&#xD;
      treatment-related functional decline and its consequences. This project aims at testing&#xD;
      feasibility and effectiveness of multimodal prehabilitation in esophageal cancer care.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      While evidence on prehabilitation is mounting, upper gastrointestinal surgery still remains&#xD;
      under-investigated. This trial aims to explore the effect of prehabilitation over the whole&#xD;
      perioperative trajectory, including neo-adjuvant treatment (NAT).&#xD;
&#xD;
      Multimodal prehabilitation includes exercise, nutrition therapy, and mental distress coping&#xD;
      strategies. In the context of a multimodal approach, the two groups follow different exercise&#xD;
      prescriptions: high-intensity interval supervised training prescribed accordingly&#xD;
      cardiopulmonary exercise testing (CPET)-derived variables, versus a home-based program. For&#xD;
      both groups, multimodal prehabilitation is prescribed over the whole preoperative period,&#xD;
      including during NAT.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 19, 2019</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxygen consumption (VO2)</measure>
    <time_frame>Change from baseline to 2 months after surgery</time_frame>
    <description>Oxygen consumption at anaerobic threshold (VO2 at AT) measured with cardiopulmonary exercise testing (CPET)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Oxygen consumption (VO2)</measure>
    <time_frame>Change from baseline to post neo-adjuvant therapy (average duration 6-8 weeks)</time_frame>
    <description>Oxygen consumption at anaerobic threshold (VO2 at AT) measured with cardiopulmonary exercise testing (CPET)</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">54</enrollment>
  <condition>Esophageal Cancer</condition>
  <arm_group>
    <arm_group_label>Supervised Prehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prehabilitation will include exercise, nutrition, and anxiety-coping intervention.&#xD;
This group will receive a supervised, in-hospital training.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Home-based Prehabilitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prehabilitation will include exercise, nutrition, and anxiety-coping intervention.&#xD;
This group will receive a home-based training.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Prehabilitation</intervention_name>
    <description>Endurance and Resistance Exercise, Nutrition therapy, reducing intervention during the whole preoperative period</description>
    <arm_group_label>Home-based Prehabilitation</arm_group_label>
    <arm_group_label>Supervised Prehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with non-metastatic esophageal cancer undergoing neo-adjuvant chemotherapy&#xD;
             and surgery.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  co-morbid medical, physical and mental conditions that contraindicate exercise or oral&#xD;
             nutrition&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Enrico M Minnella, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Francesco Carli, MD MPhil</last_name>
    <phone>514-934-1934</phone>
    <phone_ext>43274</phone_ext>
    <email>franco.carli@mcgill.ca</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Enrico M Minnella, MD PhD</last_name>
    <phone>514-934-1934</phone>
    <phone_ext>43274</phone_ext>
    <email>enrico.minnella@mail.mcgill.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>McGill University Health Centre</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3G 1A4</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francesco Carli, MD MPhil</last_name>
      <phone>5149341934</phone>
      <phone_ext>43728</phone_ext>
      <email>franco.carli@mcgill.ca</email>
    </contact>
    <investigator>
      <last_name>Enrico M Minnella, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 8, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Centre/Research Institute of the McGill University Health Centre</investigator_affiliation>
    <investigator_full_name>Franco Carli</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

